Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.

Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...

So, an elevated LDL cholesterol level is a major risk factor for heart disease and stroke. While lowering LDL cholesterol levels with statin drugs significantly reduces cardiac risk, reducing LDL ...

The high street retailer is offering its own-brand Max Strength Plant Sterols Capsules for less - but the saving is only ...

Some recent research supports taking thyroid medication at bedtime to maximize absorption. If you take a combination T3/T4 therapy or desiccated thyroid, you might have difficulty falling asleep. Talk ...

In today’s fast-paced world, maintaining good health has become increasingly challenging. With the rise in lifestyle-related ...

The good news is you can easily protect your pet from these parasites with one of the best flea and tick treatments for dogs. Many of these flea medications also treat lice, mites, intestinal ...

Lipozem is a dietary supplement designed to support weight loss through its primary ingredient natural water-soluble fiber extracted from the konjac plant This fiber expands in the stomach creating a ...